ArticleTropical diseases, travel medicine and vaccines2024

A post-marketing study to evaluate the safety and immunogenicity of a quadrivalent influenza split-virion vaccine in elderly people aged 60 years and older.

Zengqiang Kou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.